by Rich | Feb 1, 2024 | Pharmacy, Sterile Compounding, USP
The revised USP General Chapter <797> offers compounders pathways for extended beyond-use dates (BUDs) in sterile preparations, with increasing BUDs tied to stricter requirements. Compliance is emphasized as a continuous journey, according to Kevin Hansen, PharmD....
by Rich | May 1, 2023 | Compliance, Pharmacy, Sterile Compounding, USP
The Case for Automating USP Pharmacy Checklists In the ever-evolving landscape of healthcare, adherence to stringent regulatory standards and quality measures is non-negotiable. As pharmacies strive to maintain compliance and ensure patient safety, the reliance on...
by Rich | Apr 13, 2023 | Compliance
Karen Lovitch, Chair of the firm’s Health Law and Health Care Enforcement Defense Practices was interviewed for this article which was included in the January 2023 issue of Laboratory Economics. She covers the top compliance challenges faced by clinical...
